Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Lexicon Pharmaceuticals earned a third $10 million milestone payment from Novo Nordisk in 2026 for progress in Phase 1 trials of LX9851, an obesity treatment.
Global Payments Inc. (NYSE: GPN) unveiled Genius World, a four-day immersive event showcasing its Genius™ solutions, held August 24-27, 2026, in Las Vegas.
GeneDx and Seattle Children’s published a study in Genetics in Medicine demonstrating the benefits of rapid genome sequencing (rGS) across all pediatric inpatient units, not just intensive care.
Over 600 California workers diagnosed with silicosis since 2019 from artificial stone fabrication, with dozens dead and many awaiting lung transplants.
Alpha Modus and Circle The Wagons signed a strategic consulting and business development agreement on August 24, 2026, targeting the $353 billion independent grocery market.
Pasqal and Eleven Ventures agreed to form a commercial joint venture to deploy quantum computing systems across Saudi Arabia and the broader MENA region.
Saba Capital, the largest shareholder of Baillie Gifford US Growth Trust, proposed three new directors for the board: Jason Chen, Thomas H. McGlade, and Sir James Waterlow.
